STXS - Stereotaxis Stock Price, News & Analysis

$0.78 0.02 (2.63 %)
(As of 11/24/2017 08:00 AM ET)
Previous Close$0.78
Today's Range$0.80 - $0.76
52-Week Range$0.47 - $1.10
Volume26,954 shs
Average Volume49,759 shs
Market Capitalization$17.78 million
P/E Ratio3.71
Dividend YieldN/A

About Stereotaxis (OTCMKTS:STXS)

Stereotaxis logoStereotaxis, Inc. is a United States-based healthcare technology company. The Company is engaged in the development of robotic cardiology instrument navigation systems designed to enhance the treatment of arrhythmias and coronary disease. The Company also provides information management solutions for the interventional lab. The Stereotaxis platform helps physicians to provide patient care with robotic precision and enhanced integration of procedural information. The Company's Epoch solution includes the Niobe ES remote magnetic navigation system, the Odyssey portfolio of lab optimization, networking and patient information management systems, and the Vdrive robotic navigation system and consumables. The Niobe ES remote magnetic navigation system includes the Navigant software user interface and the QuikCAS catheter advancement system. The Vdrive robotic navigation system with Niobe ES magnetic navigation system provides navigation and stability for diagnostic and ablation devices.

Industry, Sector and Symbol

Industry Medical Appliances & Equipment
  • Previous Symbol: NASDAQ:STXS


    Debt-to-Equity RatioN/A
    Current Ratio0.44%
    Quick Ratio0.29%


    Trailing P/E Ratio3.71
    Forward P/E RatioN/A
    P/E GrowthN/A

    Sales & Book Value

    Annual Sales$32.16 million
    Price / Sales0.55
    Cash FlowN/A
    Price / CashN/A
    Book Value($1.06) per share
    Price / Book-0.74


    Annual DividendN/A
    Dividend YieldN/A


    Trailing EPS$0.02
    Net Income$-5,280,000.00
    Net Margins7.12%
    Return on Equity-30.95%
    Return on Assets36.99%


    Outstanding Shares22,800,000

    Frequently Asked Questions for Stereotaxis (OTCMKTS:STXS)

    What is Stereotaxis' stock symbol?

    Stereotaxis trades on the OTCMKTS under the ticker symbol "STXS."

    How were Stereotaxis' earnings last quarter?

    Stereotaxis Inc. (OTCMKTS:STXS) posted its quarterly earnings data on Monday, May, 9th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter. The medical equipment provider earned $8.60 million during the quarter, compared to the consensus estimate of $9.50 million. Stereotaxis had a net margin of 7.12% and a negative return on equity of 30.95%. View Stereotaxis' Earnings History.

    When will Stereotaxis make its next earnings announcement?

    Stereotaxis is scheduled to release their next quarterly earnings announcement on Thursday, March, 15th 2018. View Earnings Estimates for Stereotaxis.

    Who are some of Stereotaxis' key competitors?

    Who are Stereotaxis' key executives?

    Stereotaxis' management team includes the folowing people:

    • David Fischel, Chairman of the Board, Acting Chief Executive Officer (Age 30)
    • Martin C. Stammer, Chief Financial Officer (Age 36)
    • Karen W. Duros, Senior Vice President, General Counsel, Secretary (Age 62)
    • David A. Giffin, Vice President - Human Resources (Age 68)
    • Paul A. Brathwaite Ph.D., Vice President - Research & Development (Age 47)
    • Joseph E. Kiani, Director (Age 52)
    • Arun Swarup Menawat Ph.D., Director (Age 62)
    • David W. Benfer, Independent Director (Age 70)
    • Nathan Fischel M.D., Independent Director (Age 61)
    • Robert J. Messey, Independent Director (Age 71)

    How do I buy Stereotaxis stock?

    Shares of Stereotaxis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

    What is Stereotaxis' stock price today?

    One share of Stereotaxis stock can currently be purchased for approximately $0.78.

    How big of a company is Stereotaxis?

    Stereotaxis has a market capitalization of $17.78 million and generates $32.16 million in revenue each year. The medical equipment provider earns $-5,280,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Stereotaxis employs 120 workers across the globe.

    How can I contact Stereotaxis?

    Stereotaxis' mailing address is 4320 Forest Park Avenue Suite 100, ST.LOUIS MO, 63108. The medical equipment provider can be reached via phone at 314-678-6100 or via email at [email protected]

    MarketBeat Community Rating for Stereotaxis (STXS)

    Community Ranking:  2.2 out of 5 (star star)
    Outperform Votes:  31 (Vote Outperform)
    Underperform Votes:  40 (Vote Underperform)
    Total Votes:  71
    MarketBeat's community ratings are surveys of what our community members think about Stereotaxis and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

    Analyst Ratings

    Analysts' Consensus Rating for Stereotaxis (OTCMKTS:STXS)

      (How are Consensus Ratings Calculated?)
    Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
    Consensus Rating:N/A (Score: NaN)
    Analysts' Consensus Price Target: N/A

    Consensus Price Target History for Stereotaxis (OTCMKTS:STXS)

    Price Target History for Stereotaxis (OTCMKTS:STXS)

    Analysts' Ratings History for Stereotaxis (OTCMKTS:STXS)

    No equities research coverage for this company has been tracked by


    Earnings History and Estimates Chart for Stereotaxis (OTCMKTS:STXS)

    Earnings by Quarter for Stereotaxis (OTCMKTS:STXS)

    Earnings History by Quarter for Stereotaxis (OTCMKTS STXS)

    DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
    8/10/2017Q2 2017($0.02)$8.47 millionViewN/AView Earnings Details
    5/8/2017Q1 2017$0.01$6.98 millionViewListenView Earnings Details
    5/9/2016Q1($0.11)$9.50 million$8.60 millionViewListenView Earnings Details
    2/22/2016Q4($0.10)$9.80 million$9.20 millionViewListenView Earnings Details
    11/3/2015Q3($0.05)$8.90 million$9.30 millionViewListenView Earnings Details
    8/4/2015Q215($0.12)$120.60 million$9.66 millionViewN/AView Earnings Details
    5/6/2015Q115($0.15)$8.40 million$9.50 millionViewListenView Earnings Details
    2/25/2015Q414$0.04$9.10 million$9.80 millionViewListenView Earnings Details
    5/6/2014Q1($0.16)$8.40 million$8.40 millionViewListenView Earnings Details
    2/25/2014Q4($0.19)$12.20 million$9.10 millionViewListenView Earnings Details
    11/12/2013Q3($0.26)$9.70 million$10.80 millionViewN/AView Earnings Details
    8/8/2013Q2 2013($0.59)($0.37)$10.80 million$9.70 millionViewListenView Earnings Details
    5/13/2013Q1 2013($0.50)($0.61)$12.00 million$8.40 millionViewListenView Earnings Details
    11/5/2012Q312($0.72)($0.33)$10.30 million$11.60 millionViewN/AView Earnings Details
    3/5/2012($0.14)($0.10)ViewN/AView Earnings Details
    11/7/2011($0.16)($0.13)ViewN/AView Earnings Details
    8/8/2011($0.12)($0.18)ViewN/AView Earnings Details
    5/2/2011($0.13)($0.17)ViewN/AView Earnings Details
    2/28/2011($0.11)($0.05)ViewN/AView Earnings Details
    (Data available from 1/1/2011 forward)


    Earnings Estimates for Stereotaxis (OTCMKTS:STXS)

    No earnings estimates for this company have been tracked by


    Dividend History for Stereotaxis (OTCMKTS:STXS)
    No dividend announcements for this company have been tracked by

    Insider Trades

    Insider Trading and Institutional Ownership History for Stereotaxis (OTCMKTS STXS)

    Insider Ownership Percentage: 22.05%
    Institutional Ownership Percentage: 6.08%
    Insider Trades by Quarter for Stereotaxis (OTCMKTS:STXS)

    Insider Trades by Quarter for Stereotaxis (OTCMKTS STXS)

    Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
    6/15/2015Fred A MiddletonDirectorSell26,064$1.57$40,920.48View SEC Filing  
    6/12/2015Fred A MiddletonDirectorSell16,273$1.61$26,199.53View SEC Filing  
    6/9/2015Fred A MiddletonDirectorSell106,876$1.65$176,345.40View SEC Filing  
    3/13/2015David BenferDirectorBuy3,000$1.95$5,850.00View SEC Filing  
    12/12/2014William C Mills IIICEOBuy10,000$1.45$14,500.00View SEC Filing  
    12/9/2014Fred A MiddletonDirectorSell8,551$1.51$12,912.01View SEC Filing  
    12/5/2014William C Mills IIICEOBuy10,000$1.43$14,300.00View SEC Filing  
    12/3/2014Fred A MiddletonDirectorSell15,809$1.59$25,136.31View SEC Filing  
    8/11/2014William C Mills IIICEOBuy10,000$2.75$27,500.00View SEC Filing  
    3/13/2014Fred A MiddletonDirectorSell24,302$4.21$102,311.42View SEC Filing  
    8/23/2013Fred A MiddletonDirectorSell14,600$3.67$53,582.00View SEC Filing  
    8/20/2013Christopher D AlafiMajor ShareholderSell261,241$3.74$977,041.34View SEC Filing  
    8/7/2013Fred A MiddletonDirectorSell78,974$10.13$800,006.62View SEC Filing  
    11/30/2012Fred A MiddletonDirectorBuy24,360$1.53$37,270.80View SEC Filing  
    (Data available from 1/1/2013 forward)


    Latest Headlines for Stereotaxis (OTCMKTS STXS)


    Social Media



    Stereotaxis (OTCMKTS STXS) Chart for Friday, November, 24, 2017
    Loading chart…

    This page was last updated on 11/24/2017 by Staff

    Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.